These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38381969)

  • 1. μ-Opioid Receptor Activation at the Dorsal Reticular Nucleus Shifts Diffuse Noxious Inhibitory Controls to Hyperalgesia in Chronic Joint Pain in Male Rats.
    Pereira-Silva R; Teixeira-Pinto A; Neto FL; Martins I
    Anesthesiology; 2024 Jun; 140(6):1176-1191. PubMed ID: 38381969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shift of µ-opioid Receptor Signaling in the Dorsal Reticular Nucleus Is Implicated in Morphine-induced Hyperalgesia in Male Rats.
    Costa AR; Sousa M; Wilson SP; Reguenga C; Teixeira-Pinto A; Tavares I; Martins I
    Anesthesiology; 2020 Sep; 133(3):628-644. PubMed ID: 32568844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids modulate pain facilitation from the dorsal reticular nucleus.
    Pinto M; Castro AR; Tshudy F; Wilson SP; Lima D; Tavares I
    Mol Cell Neurosci; 2008 Dec; 39(4):508-18. PubMed ID: 18725300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent inflammatory pain decreases the antinociceptive effects of the mu opioid receptor agonist DAMGO in the locus coeruleus of male rats.
    Jongeling AC; Johns ME; Murphy AZ; Hammond DL
    Neuropharmacology; 2009; 56(6-7):1017-26. PubMed ID: 19265713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. μ-Opioid modulation in the rostral solitary nucleus and reticular formation alters taste reactivity: evidence for a suppressive effect on consummatory behavior.
    Kinzeler NR; Travers SP
    Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R690-700. PubMed ID: 21697523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DAMGO in the central amygdala alleviates the affective dimension of pain in a rat model of inflammatory hyperalgesia.
    Zhang RX; Zhang M; Li A; Pan L; Berman BM; Ren K; Lao L
    Neuroscience; 2013 Nov; 252():359-66. PubMed ID: 23994597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of opioid receptors in the medullary reticularis nucleus dorsalis, but not the rostral ventromedial medulla, prevents analgesia produced by diffuse noxious inhibitory control in rats with muscle inflammation.
    de Resende MA; Silva LF; Sato K; Arendt-Nielsen L; Sluka KA
    J Pain; 2011 Jun; 12(6):687-97. PubMed ID: 21330219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamus.
    Hoot MR; Sim-Selley LJ; Selley DE; Scoggins KL; Dewey WL
    Brain Res; 2011 Aug; 1406():1-7. PubMed ID: 21762883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain.
    Chen W; McRoberts JA; Marvizón JC
    Neuroscience; 2014 May; 267():67-82. PubMed ID: 24583035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse noxious inhibitory controls in chronic joint inflammatory Pain: Study of the descending serotonergic modulation mediated through 5HT3 receptors.
    Pereira-Silva R; Serrão P; Lourença Neto F; Martins I
    Neurobiol Pain; 2023; 13():100123. PubMed ID: 36915290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
    Schmidt BL; Tambeli CH; Levine JD; Gear RW
    Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain.
    Sykes KT; White SR; Hurley RW; Mizoguchi H; Tseng LF; Hammond DL
    J Pharmacol Exp Ther; 2007 Aug; 322(2):813-21. PubMed ID: 17494863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of peripheral mu-opioid receptors in inflammatory orofacial muscle pain.
    Nũnéz S; Lee JS; Zhang Y; Bai G; Ro JY
    Neuroscience; 2007 May; 146(3):1346-54. PubMed ID: 17379421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
    Kalra A; Urban MO; Sluka KA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity.
    Mandyam CD; Thakker DR; Standifer KM
    J Pharmacol Exp Ther; 2003 Sep; 306(3):965-72. PubMed ID: 12750434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.
    Araldi D; Ferrari LF; Levine JD
    J Neurosci; 2015 Sep; 35(36):12502-17. PubMed ID: 26354917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal.
    Aley KO; Green PG; Levine JD
    J Neurosci; 1995 Dec; 15(12):8031-8. PubMed ID: 8613740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stereoisomer (+)-naloxone potentiates G-protein coupling and feeding associated with stimulation of mu opioid receptors in the parabrachial nucleus.
    Chaijale NN; Aloyo VJ; Simansky KJ
    J Psychopharmacol; 2013 Mar; 27(3):302-11. PubMed ID: 23348755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G protein activation in rat ponto-mesencephalic nuclei is enhanced by combined treatment with a mu opioid and an adenosine A1 receptor agonist.
    Tanase D; Martin WA; Baghdoyan HA; Lydic R
    Sleep; 2001 Feb; 24(1):52-62. PubMed ID: 11204054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.